A randomized controlled trial to compare the effects of sulphonylurea gliclazide MR (modified release) and the DPP-4 inhibitor vildagliptin on glycemic variability and control measured by continuous glucose monitoring (CGM) in Brazilian women with type 2 diabetes

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: Diabetes Research and Clinical Practice

Abbreviated Title: Diabetes Research and Clinical Practice

Publisher: Elsevier BV

ISSN (Print): 01688227

Publication date Created: May 2018

Publication date (Print): May 2018

Volume: 139

Pages: 357-365

Article

DOI: 10.1016/j.diabres.2018.03.035

PubMed ID: 29596951

SO-VID: 4a46639f-3f1a-427e-8b15-4cbb2eb3255d

License:

https://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Comments

Comment on this article

scite_

Cited by 9

See all cited by